Clinicopathologic characteristics, outcomes, and prognostic factors of angioimmunoblastic T‐cell lymphoma in China

Abstract

Patients with AITL were mainly treated with anthracycline-based regimens, and the outcomes were still unsatisfactory in China. Our novel prognostic model may improve our ability to identify patients at different risks for alternative therapies.